Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,741 | -6,903 | -30,340 | -20,669 | -11,211 |
| Depreciation Amortization | 113 | 56 | 126 | 69 | 16 |
| Other Working Capital | -3,418 | -3,554 | -3,086 | -1,398 | -1,274 |
| Other Operating Activity | 3,422 | 1,536 | 4,796 | 3,274 | 1,668 |
| Operating Cash Flow | $-13,624 | $-8,865 | $-28,504 | $-18,724 | $-10,801 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | -15,000 | -15,000 | -15,000 |
| Other Investing Activity | 0 | 0 | -15,000 | -15,000 | -15,000 |
| Investing Cash Flow | $N/A | $N/A | $-15,000 | $-15,000 | $-15,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 14,951 | 14,951 | 14,951 |
| Common Stock Issued | 729 | 729 | 81,406 | 81,406 | 28,464 |
| Financing Cash Flow | $729 | $729 | $96,357 | $96,357 | $43,415 |
| Exchange Rate Effect | -702 | 55 | -10 | -129 | -61 |
| Beginning Cash Position | 74,810 | 74,810 | 21,967 | 21,967 | 21,967 |
| End Cash Position | 61,213 | 66,729 | 74,810 | 84,471 | 39,520 |
| Net Cash Flow | $-13,597 | $-8,081 | $52,843 | $62,504 | $17,553 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,624 | -8,865 | -28,504 | -18,724 | -10,801 |
| Free Cash Flow | -13,624 | -8,865 | -28,504 | -18,724 | -10,801 |